Literature DB >> 25546764

B cell modulation in transplantation.

M R Clatworthy1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25546764      PMCID： PMC4285493          DOI： 10.1111/cei.12513

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  27 in total

1.  Identification of a B cell signature associated with renal transplant tolerance in humans.

Authors:  Kenneth A Newell; Adam Asare; Allan D Kirk; Trang D Gisler; Kasia Bourcier; Manikkam Suthanthiran; William J Burlingham; William H Marks; Ignacio Sanz; Robert I Lechler; Maria P Hernandez-Fuentes; Laurence A Turka; Vicki L Seyfert-Margolis
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

2.  Five-year outcomes in living donor kidney transplants with a positive crossmatch.

Authors:  A Bentall; L D Cornell; J M Gloor; W D Park; M J Gandhi; J L Winters; M F Chedid; P G Dean; M D Stegall
Journal:  Am J Transplant       Date:  2012-10-16       Impact factor: 8.086

3.  Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFF.

Authors:  Ronald F Parsons; Ming Yu; Kumar Vivek; Ghazal Zekavat; Susan Y Rostami; Amin S Ziaie; Yanping Luo; Brigitte Koeberlein; Robert R Redfield; Christopher D Ward; Thi-Sau Migone; Michael P Cancro; Ali Naji; Hooman Noorchashm
Journal:  Transplantation       Date:  2012-04-15       Impact factor: 4.939

4.  BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies.

Authors:  A Thibault-Espitia; Y Foucher; R Danger; T Migone; A Pallier; S Castagnet; C G-Gueguen; A Devys; A C-Gautier; M Giral; J-P Soulillou; S Brouard
Journal:  Am J Transplant       Date:  2012-08-06       Impact factor: 8.086

5.  CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Authors:  Paul A Blair; Lina Yassin Noreña; Fabian Flores-Borja; David J Rawlings; David A Isenberg; Michael R Ehrenstein; Claudia Mauri
Journal:  Immunity       Date:  2010-01-14       Impact factor: 31.745

6.  BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses.

Authors:  Qunrui Ye; Liqing Wang; Andrew D Wells; Ran Tao; Rongxiang Han; Anne Davidson; Martin L Scott; Wayne W Hancock
Journal:  Eur J Immunol       Date:  2004-10       Impact factor: 5.532

7.  Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection.

Authors:  Gemma Banham; Davide Prezzi; Sarah Harford; Craig J Taylor; Rizwan Hamer; Rob Higgins; J Andrew Bradley; Menna R Clatworthy
Journal:  Transplantation       Date:  2013-08-27       Impact factor: 4.939

8.  Antibody-mediated vascular rejection of kidney allografts: a population-based study.

Authors:  Carmen Lefaucheur; Alexandre Loupy; Dewi Vernerey; Jean-Paul Duong-Van-Huyen; Caroline Suberbielle; Dany Anglicheau; Jérôme Vérine; Thibaut Beuscart; Dominique Nochy; Patrick Bruneval; Dominique Charron; Michel Delahousse; Jean-Philippe Empana; Gary S Hill; Denis Glotz; Christophe Legendre; Xavier Jouven
Journal:  Lancet       Date:  2012-11-23       Impact factor: 79.321

9.  One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial.

Authors:  Bénédicte Sautenet; Gilles Blancho; Mathias Büchler; Emmanuel Morelon; Olivier Toupance; Benoit Barrou; Didier Ducloux; Valérie Chatelet; Bruno Moulin; Caroline Freguin; Marc Hazzan; Philippe Lang; Christophe Legendre; Pierre Merville; Georges Mourad; Christine Mousson; Claire Pouteil-Noble; Raj Purgus; Jean-Philippe Rerolle; Johnny Sayegh; Pierre-François Westeel; Philippe Zaoui; Hedia Boivin; Amélie Le Gouge; Yvon Lebranchu
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

10.  IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.

Authors:  Ping Shen; Toralf Roch; Vicky Lampropoulou; Richard A O'Connor; Ulrik Stervbo; Ellen Hilgenberg; Stefanie Ries; Van Duc Dang; Yarúa Jaimes; Capucine Daridon; Rui Li; Luc Jouneau; Pierre Boudinot; Siska Wilantri; Imme Sakwa; Yusei Miyazaki; Melanie D Leech; Rhoanne C McPherson; Stefan Wirtz; Markus Neurath; Kai Hoehlig; Edgar Meinl; Andreas Grützkau; Joachim R Grün; Katharina Horn; Anja A Kühl; Thomas Dörner; Amit Bar-Or; Stefan H E Kaufmann; Stephen M Anderton; Simon Fillatreau
Journal:  Nature       Date:  2014-02-23       Impact factor: 49.962
View more
  1 in total

1.  mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.

Authors:  Christina L Avila; Jason M Zimmerer; Steven M Elzein; Thomas A Pham; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2016-09       Impact factor: 4.939
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.